ダウンロード数: 311
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
61_4_147.pdf | 697.53 kB | Adobe PDF | 見る/開く |
タイトル: | 函館五稜郭病院におけるHigh risk前立腺癌の臨床的検討 |
その他のタイトル: | Outcomes of High-Risk Prostate Cancer Patients at Hakodate Goryoukaku Hospital |
著者: | 柴森, 康介 福多, 史昌 武藤, 雅俊 高橋, 敦 高木, 良雄 |
著者名の別形: | Shibamori, Kosuke Fukuta, Fumimasa Muto, Masatoshi Takahashi, Atsushi Takagi, Yoshio |
キーワード: | Prostate cancer High risk Prognosis Radical prostatectomy |
発行日: | Apr-2015 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 61 |
号: | 4 |
開始ページ: | 147 |
終了ページ: | 151 |
抄録: | We assessed the outcomes of high-risk prostate cancer patients who received radical prostatectomy (RP), external beamradiation therapy (EBRT) or androgen deprivation therapy (ADT). Two hundred nineteen patients who were diagnosed with pathologically confirmed high-risk prostate cancer as defined by D’Amico between 2005 and 2011 were included in this study. Of them, 74 patients underwent RP. The 5-year cancer-specific survival (5yCSS) and 5-year PSA recurrence-free survival (5yPRFS) rates were 100 and 67.2%, respectively. A positive surgical margin and Gleason score≧8 were risk factors for PSA recurrence. The 5yPRFSs were 100, 74.4% and ‘unmeasurable’ for patients with 0, 1 and 2 risk factors, respectively. Ninety patients underwent EBRT. The 5yCSS and 5yPRFS rates were 95.2 and 74.2%, respectively. Fifty-five patients underwent ADT alone. Their 5yCSS and 5yPRFS rates were 93. 3 and 64. 3%, respectively. There was no significant difference in 5yCSS and 5yPRFS rates among the treatment groups. These results show that RP can be a treatment option for high-risk prostate cancer patients. |
著作権等: | 許諾条件により本文は2016/05/01に公開 |
URI: | http://hdl.handle.net/2433/198261 |
PubMed ID: | 26037673 |
出現コレクション: | Vol. 61 No. 4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。